insights_auto
Why is ANW down 4,88%?
Dive Deeperchevron_right
ANW:FRA
Immuron Ltd
ā¬0,020
arrow_downward
-4,88%(-0,0010) 1D
9 Okt., 22:00:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ANW...
Open
ā¬0,02
High
ā¬0,02
Low
ā¬0,02
Mkt. cap
10,10Ā m
Avg. vol.
627,00
Volume
0,00
52-wk high
ā¬0,04
52-wk low
ā¬0,01
No. of employees
8
Open
ā¬0,02
High
ā¬0,02
Low
ā¬0,02
Mkt. cap
10,10Ā m
Avg. vol.
627,00
Volume
0,00
52-wk high
ā¬0,04
52-wk low
ā¬0,01
No. of employees
8
News stories
From web sources and news partners
Benzinga
·
1 uur gelede
S&P 500 Earnings Preview: Will Strong Profits Fuel the Next Rally?
Yahoo Finance
·
1 uur gelede
The Nasdaq-100 Has Gained 20% or More 3 Years Running. This Streak Rests on Far Stronger Earnings Than 1999's.
The Globe and Mail
·
1 uur gelede
Lunai Bioworks Seeks Nasdaq Trading Suspension Amid Probe
Seeking Alpha
·
4 uur gelede
The 1-Minute Market Report October 10, 2026 (NYSEARCA:VOO)
Profile
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
About Immuron Ltd
CEO-
Employees8
Founded1994
HeadquartersBlackburn North, Victoria, Australiƫ
Sector-
Websiteimmuron.com.au